首页> 外国专利> BLOOD CELL-FREE DNA-BASED METHOD FOR PREDICTING PROGNOSIS OF LIVER CANCER TREATMENT

BLOOD CELL-FREE DNA-BASED METHOD FOR PREDICTING PROGNOSIS OF LIVER CANCER TREATMENT

机译:基于无血细胞DNA的肝癌治疗预后预测方法

摘要

The present invention relates to a blood cell-free DNA-based method for predicting the prognosis of liver cancer treatment. A method for predicting the prognosis of liver cancer, according to the present invention, uses next generation sequencing (NGS) so as to increase the accuracy of prognosis prediction of a liver cancer patient and also increase the accuracy of prognosis prediction based on a very low concentration cell-free DNA of which detection has been difficult, thereby increasing the commercial utilization thereof. Therefore, the method of the present invention is useful for determining the prognosis of a liver cancer patient.
机译:本发明涉及基于无血细胞DNA的预测肝癌治疗预后的方法。根据本发明的用于预测肝癌预后的方法使用下一代测序(NGS),以提高肝癌患者的预后预测的准确性,并且还基于非常低的预后而提高预后预测的准确性。浓缩难以检测的无细胞DNA,从而提高其商业用途。因此,本发明的方法可用于确定肝癌患者的预后。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号